Liver can also produce EPO to promote erythropoiesis in an oxygen-dependent mode, but it is not sufficient to compensate the loss of kidney EPO in end-stage renal disease, leading to anemia that requires systemic treatment with recombinant EPO [87]. The gene discussed is EPO; the disease is stage 5 chronic kidney disease.